Auralife Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -123.41%
- Ebitda -74.63%
- Net Worth -11.00%
- Total Assets -17.60%
About Auralife Healthcare India
Auralife Healthcare India Private Limited (AHIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2012 and has a history of 12 years and two months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Srikumar Vignesh and Ayyappan Jalajavathy serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52100TN2012PTC088642
-
Company No.
088642
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 2012
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Auralife Healthcare India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srikumar Vignesh
|
Director | 21-Aug-2017 | Current |
|
Ayyappan Jalajavathy
|
Additional Director | 13-May-2022 | Current |
Financial Performance of Auralife Healthcare India.
Auralife Healthcare India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 123.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auralife Healthcare India?
In 2018, Auralife Healthcare India had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Herbocare Hospital Private LimitedSrikumar Vignesh is a mutual person
-
Dr.Navinbalaji Naturals India Private LimitedSrikumar Vignesh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Auralife Healthcare India?
Unlock and access historical data on people associated with Auralife Healthcare India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auralife Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auralife Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
